ORBIMED ADVISORS LLC - 12 May 2025 SCHEDULE 13D/A Report for CORVUS PHARMACEUTICALS, INC. Common stock, par value $0.0001 per share (the "Shares"). (CRVS)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED ADVISORS LLC
Security: CORVUS PHARMACEUTICALS, INC. Common stock, par value $0.0001 per share (the "Shares").
Symbol: CRVS
Shares outstanding: 80,208,385 shares
Disclosed Ownership: 9,785,423 shares
Ownership: 12%
Form type: SCHEDULE 13D/A
Filing time: 14 May 2025, 20:49:03 UTC
Date of event: 12 May 2025
Previous filing: 01 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	12%	9,785,423	0	9,785,423	/s/ Carl L. Gordon	Carl L. Gordon/Member	0001055951
ORBIMED CAPITAL GP V LLC	12%	9,785,423	0	9,785,423	/s/ Carl L. Gordon	Carl L. Gordon/Member of OrbiMed Advisors LLC	0001615374